Product
Herombopag
3 clinical trials
4 indications
Indication
Immune ThrombocytopeniaIndication
Aplastic AnemiaIndication
UntreatedIndication
Drug EffectClinical trial
Extension Study of Herombopag in Children and Adolescents With Chronic Primary Immune ThrombocytopeniaStatus: Not yet recruiting, Estimated PCD: 2024-06-30
Clinical trial
The Efficacy and Safety of Herombopag Combined With Cyclosporine for Patients With Non Severe Aplastic AnemiaStatus: Recruiting, Estimated PCD: 2024-11-30
Clinical trial
A Prospective, Randomized, Controlled Study of rhTPO in Combination With Herombopag + CsA vs Herombopag + CsA for the Treatment of Primary Transfusion-dependent NSAAStatus: Not yet recruiting, Estimated PCD: 2024-08-01